An Advanced Intrahepatic Cholangiocarcinoma Patient Benefits from Personalized Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An Advanced Intrahepatic Cholangiocarcinoma Patient Benefits from Personalized Immunotherapy

Published:2024-03-16 Issue: Volume: Page:
ISSN:0360-3997
Container-title:Inflammation
language:en
Short-container-title:Inflammation

Author:

Zhu Sihui,Liu Chenxi,Jin Yunchen,Zhang Hailong,Zhou Mingzhen,Xu Chen,Shao Jie,Liu Qin,Wei Jia,Shen Jie,Liu Baorui

Funder

National Natural Science Foundation of Nanjing University of Chinese Medicine

The Hospital Management Research of Nanjing Drum Tower Hospital

Medical Research of Jiangsu Health Committee

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10753-024-02003-8.pdf

Reference24 articles.

1. Brindley, P.J., M. Bachini, S.I. Ilyas, et al. 2021. Cholangiocarcinoma. Nature Reviews Disease Primers 7 (1): 65. https://doi.org/10.1038/s41572-021-00300-2.

2. Dodson, R.M., M.J. Weiss, D. Cosgrove, et al. 2013. Intrahepatic cholangiocarcinoma: management options and emerging therapies. Journal of the American College of Surgeons 217 (4): 736-750.e4. https://doi.org/10.1016/j.jamcollsurg.2013.05.021.

3. Jarnagin, W.R., Y. Fong, R.P. DeMatteo, et al. 2001. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Annals of Surgery 234 (4): 507–17. https://doi.org/10.1097/00000658-200110000-00010.

4. Hong, J.C., C.M. Jones, J.P. Duffy, et al. 2011. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. Archives of Surgery 146 (6): 683–9. https://doi.org/10.1001/archsurg.2011.116.

5. Schumacher, T.N., and R.D. Schreiber. 2015. Neoantigens in cancer immunotherapy. Science 348 (6230): 69–74. https://doi.org/10.1126/science.aaa4971.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3